Infinity to Present at Upcoming Conferences

• Press Release
• Source: Infinity Pharmaceuticals, Inc.
• On 7:30 am EST, Tuesday November 10, 2009

CAMBRIDGE, Mass., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI - News), an innovative cancer drug discovery and development company, today announced that management will present a company overview at two upcoming conferences.

Related Quotes

Symbol	Price	Change
INFI	6.19	0.00

{"s" : "infi","k" : "c10,l10,p20,t10","o" : "","j" : ""}

 * Jeffrey K. Tong, Ph.D., Vice President, Corporate and Product
   Development, will present at the Lazard Capital Markets 6th
   Annual Healthcare Conference in New York City on
   November 17, 2009 at 1:40 p.m. EST.

 * Gerald E. Quirk, Vice President, Corporate Affairs and General
   Counsel, will present at the Piper Jaffray 21st Annual Health
   Care Conference in New York City on December 1, 2009 at
   8:00 a.m. EST.

A live webcast of Infinity's presentations will be accessible on the company's website at http://www.infi.com.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 chaperone inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.

Infinity Pharmaceuticals, Inc.
Monique Allaire
617-453-1105
Monique.Allaire@infi.com
http://www.infi.com